Children and caregiver proxy quality of life from peanut oral immunotherapy trials
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12213
Abstract: Abstract Background Health‐related quality of life (HRQoL) is significantly and substantially reduced in individuals with peanut allergy due to many factors associated with unanticipated or potentially fatal reactions. Further insight on the impact of peanut… read more here.
Keywords: caregiver proxy; quality life; oral immunotherapy; peanut oral ... See more keywords
Peanut oral immunotherapy dose variations do not result in allergic reactions
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.12837
Abstract: 1. Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update2014. J Allergy Clin Immunol. 2014;134:1016-1025. 2. Nowak-Węgrzyn A. Food proteininduced enterocolitis syndrome and allergic proctocolitis. Allergy Asthma Proc. 2015;36:172-184. 3.… read more here.
Keywords: oral immunotherapy; immunotherapy dose; dose variations; allergy ... See more keywords
HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.941839
Abstract: Rationale Previous studies identified an interaction between HLA and oral peanut exposure. HLA-DQA1*01:02 had a protective role with the induction of Ara h 2 epitope-specific IgG4 associated with peanut consumption during the LEAP clinical trial… read more here.
Keywords: hla dqa1; hla; peanut; oral immunotherapy ... See more keywords